BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23143723)

  • 1. Cognitive trajectories in 4 patients with pediatric-onset multiple sclerosis: serial evaluation over a decade.
    Marin SE; Banwell BB; Till C
    J Child Neurol; 2013 Dec; 28(12):1577-86. PubMed ID: 23143723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age of onset as a moderator of cognitive decline in pediatric-onset multiple sclerosis.
    Hosseini B; Flora DB; Banwell BL; Till C
    J Int Neuropsychol Soc; 2014 Sep; 20(8):796-804. PubMed ID: 25033163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis.
    Till C; Racine N; Araujo D; Narayanan S; Collins DL; Aubert-Broche B; Arnold DL; Banwell B
    Neuropsychology; 2013 Mar; 27(2):210-9. PubMed ID: 23527649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
    Parrish JB; Farooq O; Weinstock-Guttman B
    Neurodegener Dis Manag; 2014; 4(2):137-46. PubMed ID: 24832031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functioning in children with multiple sclerosis.
    Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E
    Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
    Charvet LE; O'Donnell EH; Belman AL; Chitnis T; Ness JM; Parrish J; Patterson M; Rodriguez M; Waubant E; Weinstock-Guttman B; Krupp LB;
    Mult Scler; 2014 Oct; 20(11):1502-10. PubMed ID: 24687807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between global cognitive decline and depressive symptoms in multiple sclerosis.
    Barwick FH; Arnett PA
    Clin Neuropsychol; 2011 Feb; 25(2):193-209. PubMed ID: 21246447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal neuropsychological assessment in pediatric multiple sclerosis.
    MacAllister WS; Christodoulou C; Milazzo M; Krupp LB
    Dev Neuropsychol; 2007; 32(2):625-44. PubMed ID: 17931122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological profile of multiple sclerosis].
    Arango-Lasprilla JC; DeLuca J; Chiaravalloti N
    Psicothema; 2007 Feb; 19(1):1-6. PubMed ID: 17295976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.
    Achiron A; Polliack M; Rao SM; Barak Y; Lavie M; Appelboim N; Harel Y
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):744-9. PubMed ID: 15834042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive, but not mood dysfunction develops in multiple sclerosis during 7 years of follow-up.
    Haase CG; Tinnefeld M; Daum I; Ganz RE; Haupts M; Faustmann PM
    Eur Neurol; 2004; 52(2):92-5. PubMed ID: 15273430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychiatric and cognitive aspectos of multiple sclerosis].
    Carrá A; Drake M
    Vertex; 2002; 13(49):217-25. PubMed ID: 12404024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual variability in speed of information processing: an index of cognitive impairment in multiple sclerosis.
    Bodling AM; Denney DR; Lynch SG
    Neuropsychology; 2012 May; 26(3):357-67. PubMed ID: 22563876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.